Drug class
Tenofovir is a specific active antiretroviral drug substance rather than an independent therapeutic drug class, belonging pharmacologically to the class of nucleotide reverse transcriptase inhibitors (NtRTIs). Read more about Tenofovir
58 drugs in this class 29 manufacturers
Tenofovir is a specific active antiretroviral drug substance rather than an independent therapeutic drug class, belonging pharmacologically to the class of nucleotide reverse transcriptase inhibitors (NtRTIs).
Administered clinically as prodrug formulations—primarily tenofovir disoproxil fumarate or tenofovir alafenamide—it is intracellularly converted into its active diphosphate metabolite.
This active metabolite inhibits viral reverse transcriptase and viral DNA polymerase enzymes, terminating the viral DNA chain and thereby halting viral replication.
Agents containing tenofovir are central components in regimens utilized for the prevention and treatment of human immunodeficiency virus type 1 (HIV-1) infection and the management of chronic hepatitis B virus (HBV) infection.
Tenofovir is a specific active antiretroviral drug substance rather than an independent therapeutic drug class, belonging pharmacologically to the class of nucleotide reverse transcriptase inhibitors (NtRTIs)
Tenofovir is a specific active antiretroviral drug substance rather than an independent therapeutic drug class, belonging pharmacologically to the class of nucleotide reverse transcriptase inhibitors (NtRTIs)
Tenofovir is a specific active antiretroviral drug substance rather than an independent therapeutic drug class, belonging pharmacologically to the class of nucleotide reverse transcriptase inhibitors (NtRTIs)
Administered clinically as prodrug formulations—primarily tenofovir disoproxil fumarate or tenofovir alafenamide—it is intracellularly converted into its active diphosphate metabolite
Administered clinically as prodrug formulations—primarily tenofovir disoproxil fumarate or tenofovir alafenamide—it is intracellularly converted into its active diphosphate metabolite This active metabolite inhibits viral reverse transcriptase and viral DNA polymerase enzymes, terminating the viral DNA chain and thereby halting viral replication Agents containing tenofovir are central components in regimens utilized for the prevention and treatment of human immunodeficiency virus type 1 (HIV-1) ...
This active metabolite inhibits viral reverse transcriptase and viral DNA polymerase enzymes, terminating the viral DNA chain and thereby halting viral replication
Agents containing tenofovir are central components in regimens utilized for the prevention and treatment of human immunodeficiency virus type 1 (HIV-1) infection and the management of chronic hepatitis B virus (HBV) infection
Following a drug class requires a free Physicians Office Resource account.
